Implications of Helicobacter pylori infection for stomach cancer prevention

Accumulating evidence has implicated Helicobacter pylori, an established cause of chronic gastritis and peptic ulcer, in the etiology of gastric cancer. Control of this infection would reduce the occurrence of chronic gastritis and peptic ulcer and might substantially lower the risk of stomach cance...

Full description

Saved in:
Bibliographic Details
Main Author: Karen J. Goodman (Author)
Format: Book
Published: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_85abf0932c5243dba205c39e4b6e93f9
042 |a dc 
100 1 0 |a Karen J. Goodman  |e author 
245 0 0 |a Implications of Helicobacter pylori infection for stomach cancer prevention 
260 |b Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz. 
500 |a 1678-4464 
520 |a Accumulating evidence has implicated Helicobacter pylori, an established cause of chronic gastritis and peptic ulcer, in the etiology of gastric cancer. Control of this infection would reduce the occurrence of chronic gastritis and peptic ulcer and might substantially lower the risk of stomach cancer as well. The public health impact of this infectious agent warrants efforts to identify preventive measures. This paper reviews the evidence linking H. pylori infection to gastric cancer and evaluates the potential for control in high-risk populations. Current obstacles to H. pylori control are discussed, including the link to poor socioeconomic conditions, difficulty in identifying incident cases, lack of natural immunity to reinfection, limited effectiveness of antibiotic therapy in high-prevalence populations, and incomplete knowledge regarding the reservoir of infection, mode of transmission, host susceptibility factors, and the potential for developing an effective vaccine. Worthwhile avenues of research include studies designed to identify modifiable risk factors for acquisition of the infection, modifiable host factors that may increase resistance to chronic infection, more effective antibiotic therapies, and effective vaccines. 
546 |a EN 
546 |a ES 
546 |a PT 
690 |a Helicobacter pylori 
690 |a Prevention 
690 |a Stomach 
690 |a Cancer 
690 |a Epidemiology 
690 |a Medicine 
690 |a R 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Cadernos de Saúde Pública, Vol 13, Iss suppl 1, Pp S15-S25 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X1997000500003&lng=en&tlng=en 
787 0 |n https://doaj.org/toc/1678-4464 
856 4 1 |u https://doaj.org/article/85abf0932c5243dba205c39e4b6e93f9  |z Connect to this object online.